The Food and Drug Administration’s penchant for “guidance” documents as opposed to formal rulemaking needs to end, according to a business-oriented public interest legal foundation.
“FDA’s turn away
The Supreme Court has granted the government an extra 30 days to respond to request that the high court review a ruling by the 8th U.S. Circuit Court of